Suppr超能文献

依托咪酯用于脓毒症或脓毒性休克患者的插管——我们接下来该何去何从?

Etomidate for intubation of patients who have sepsis or septic shock--where do we go from here?

作者信息

Griesdale Donald E G

出版信息

Crit Care. 2012 Dec 27;16(6):189. doi: 10.1186/cc11889.

Abstract

Etomidate is an intravenous induction agent that is associated with hemodynamic stability during intubation. The agent is therefore attractive for use in critically ill patients who have a high risk of hemodynamic instability during this procedure. However, etomidate causes adrenal suppression, which itself has been associated with increased mortality in critically ill patients. The ongoing debate surrounding use of etomidate is thus centered on the immediate favorable hemodynamic profile versus the long-term risks of adrenal insufficiency, particularly in patients who have severe sepsis or septic shock.

摘要

依托咪酯是一种静脉诱导剂,在插管过程中与血流动力学稳定性相关。因此,该药物对于在此过程中存在血流动力学不稳定高风险的重症患者具有吸引力。然而,依托咪酯会导致肾上腺抑制,而这本身与重症患者死亡率增加有关。因此,围绕依托咪酯使用的持续争论集中在其即时有利的血流动力学特征与肾上腺功能不全的长期风险之间,尤其是在患有严重脓毒症或脓毒性休克的患者中。

相似文献

9

本文引用的文献

5
Hydrocortisone therapy for patients with septic shock.氢化可的松治疗感染性休克患者。
N Engl J Med. 2008 Jan 10;358(2):111-24. doi: 10.1056/NEJMoa071366.
8
Etomidate and intensive care physicians.依托咪酯与重症监护医师。
Intensive Care Med. 2005 Oct;31(10):1453; author reply 1454. doi: 10.1007/s00134-005-2754-6. Epub 2005 Aug 11.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验